Tag: Hancock Jaffe

Hancock Jaffe Laboratories Receives Medical Research Committee Approval for First-in-Human VenoValve Study

IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in bioprosthetic medical devices that establish improved standards of care for treating cardiac and vascular diseases, today announced that it has received approval for the first-in-human testing of its VenoValve® bioprosthetic medical […]

Hancock Jaffe Laboratories Receives Ethics Committee Approval for First-in-Human VenoValve Study

IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has received approval from the Ethics Committee at Fundación Santa Fe de Bogotá […]

Hancock Jaffe Appoints Bob Rankin as Chief Financial Officer

IRVINE, Calif., July 13, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that Bob Rankin will be joining the company as its chief financial officer beginning July […]

Hancock Jaffe Laboratories to Conduct Analysis for FDA Submission Package for Bioprosthetic Heart Valve

IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has initiated an analysis of its bioprosthetic heart valve in order to determine […]

Hancock Jaffe Laboratories Selects Site for First-in-Human VenoValve Study

IRVINE, Calif., June 20, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has selected Fundación Santa Fe de Bogotá (“FSFB”), in Bogota Columbia, as the […]

Hancock Jaffe Laboratories, Inc. Announces Closing of $7.5 Million Initial Public Offering

IRVINE, Calif., June 05, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (“HJLI”), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced the closing of its previously announced initial public offering of 1,500,000 units, each unit consisting of […]

Hancock Jaffe Laboratories, Inc. Announces Pricing of Initial Public Offering

IRVINE, Calif., May 31, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (“HJLI”), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced the pricing of its initial public offering of 1,500,000 units, each unit consisting of one share […]